IASIC Speaker Series Presents Impaired Driving in a Climate of Cannabis Commercialization: Lessons from Colorado for the Nation

The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed, organized, and guided by doctors.

Session: Impaired Driving in a Climate of Cannabis Commercialization: Lessons from Colorado for the Nation
Presented By: Robert L. DuPont, MD; Ed Wood, MBA
Date: Tuesday, March 8, 2022
Time: 1:00PM Eastern/10:00AM Pacific
Price: FREE

This session will present data on the role of cannabis in impaired driving from the state of Colorado, ground zero for cannabis commercialization. What policies have been adopted to detect and deter cannabis-impaired driving – and have they worked? The data may surprise you. In this session, Dr. Robert DuPont and Mr. Ed Wood will discuss the policy solutions that are needed at the local, state, and national levels to reduce the adverse impact of polysubstance use on our roads.

Register for this FREE Session

View Upcoming Sessions

Like this article?

Share on Facebook
Share on Twitter
Share on Linkdin
Share on Pinterest

Related Posts

Libby Stuyt Interview on Randy Tobler show

Exciting News! Libby Stuyt’s Interview on Randy Tobler Show! Hey everyone, we wanted to share some thrilling news! The brilliant Dr. Libby Stuyt recently had an enlightening interview on Randy Tobler Show. Dr. Stuyt is known for her groundbreaking work in the field of addiction medicine and mental health. Her insights are nothing short of

Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies

Introduction Cannabis contains over 100 cannabinoids, of which Δ9-tetrahydrocannabinol and cannabidiol are the most clinically relevant. Tetrahydrocannabinol is a partial agonist at CB1 and binds CB2 receptors. CB1 is widely expressed by central and peripheral neurones but also by immune cells and other type of cells in the brain and in the periphery, and when

Medical marijuana access and prolonged opioid use among adolescents and young adults

Abstract Background and Objectives Laws liberalizing access to medical marijuana are associated with reduced opioid analgesic use among adults, but little is known about the impact of such policies on adolescents and young adults. Methods This retrospective cohort study used 2005 to 2014 claims from MarketScan® Commercial database, which covers all 50 states and Washington

Scroll to Top